CHoKI-based MPC for blood glucose regulation in Artificial Pancreas
This work presents a Model Predictive Control (MPC) for the artificial pancreas, which is able to autonomously manage basal insulin injections in type 1 diabetic patients. Specifically, the MPC goal is to maintain the patients' blood glucose level inside the safe range of 70-180 mg/dL, acting on the insulin amount and respecting all the imposed constraints, taking into consideration also the Insulin On Board (IOB), to avoid excess of insulin infusion. MPC uses a model to make predictions of the system behaviour. In this work, due to the complexity of the diabetes disease that complicates the identification of a general physiological model, a data-driven learning method is employed instead. The Componentwise H\"{o}lder Kinky Inference (CHoKI) method is adopted, to have a customized controller for each patient. For the data collection phase and also to test the proposed controller, the virtual patients of the FDA-accepted UVA/Padova simulator are exploited. The proposed MPC is also tested on a modified version of the simulator, that takes into consideration also the variability of the insulin sensitivity. The final results are satisfying since the proposed controller reduces the time in hypoglycemia (which is more dangerous) if compared to the outcome obtained with the standard constant basal insulin therapy provided by the simulator, satisfying also the time in range requirements and avoiding long-term hyperglycemia events.
Code (0)
등록된 구현이 없습니다.
Tasks
Model Predictive ControlSimilar Papers 제목 키워드 기반
Glucagon and insulin production in pancreatic cells modeled using Petri nets and Boolean networks
Diabetes is a civilization chronic disease characterized by a constant elevated concentration of glucose in the blood. Many processes are involved in the glucose regulation, and their interactions are very complex. To be…
A contraction theory approach to observer-based controller design for glucose regulation in type 1 diabetes with intra-patient variability
While the Artificial Pancreas is effective in regulating the blood glucose in the safe range of 70-180 mg/dl in type 1 diabetic patients, the high intra-patient variability, as well as exogenous meal disturbances, poses …
An LMI-based Robust Fuzzy Controller for Blood Glucose Regulation in Type 1 Diabetes
This paper presents a control algorithm for creating an artificial pancreas for type 1 diabetes, factoring in input saturation for a practical application. By utilizing the parallel distributed compensation and Takagi-Su…
Personalized Understanding of Blood Glucose Dynamics via Mobile Sensor Data
Continuous Blood Glucose (CGM) monitors have revolutionized the ability of diabetics to manage their blood glucose, and paved the way for artificial pancreas systems. In this paper we augment CGM data with sensor input c…
Stacked LSTM Based Deep Recurrent Neural Network with Kalman Smoothing for Blood Glucose Prediction
Blood glucose (BG) management is crucial for type-1 diabetes patients resulting in the necessity of reliable artificial pancreas or insulin infusion systems. In recent years, deep learning techniques have been utilized f…
ManagementPrediction